| abstract |
The invention relates to medicine, namely to Oncology, and can be used for the prevention of respiratory complications in patients after surgical treatment of lung cancer. For this, for three days before the operation, a nebulizer therapy is carried out with daily inhalations of a mixture of 1 ml lasolvan solution, berodual 1 ml and nat. a solution of 0.9% - 2 ml, which is carried out daily, three times a day for 10 minutes. An hour before the operation, the patient is undergoing catheterization of the epidural space at the level of Th 4-5; A daily dose of a broad-spectrum antibiotic is administered intravenously. During the operation, after performing the main stage, the patient from the pleural cavity in the region of the costal-vertebral articulation and the sterno-costal region at the level of the performed thoracotomy, as well as above and below the intercostal space, is administered with a lymphotropic mixture of drugs containing 0.2% naropin - 20 ml, lidazu 32 ED, 5 ml of 5% glucose solution, ceftriaxone 1.0 mg. In the early postoperative period immediately after extubation, sanitization fibrobronchoscopy is performed. In the postoperative period, for 48 hours, a 0.2% solution of naropin is injected through the epidural catheter using an infusion pump at a rate of 2-4 ml / h. From the first day after the operation, continue nebulizer therapy; activate the patient a day after surgery. The method provides a reduction in the risk of respiratory disorders and a favorable outcome of surgical treatment due to the complex effect on causal factors that play a role in the development of complications in the perioperative period. 1 pr. |